Northwestern Mutual Investment Management Company’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.17M | Sell |
9,548
-98
| -1% | -$55.2K | 0.06% | 96 |
|
|
2026
Q1 | $5.72M | Buy |
9,646
+12
| +0.1% | +$5.98K | 0.09% | 67 |
|
|
2025
Q4 | $4.69M | Sell |
9,634
-447
| -4% | -$208K | 0.05% | 91 |
|
|
2025
Q3 | $4.23M | Buy |
10,081
+10
| +0.1% | +$3.36K | 0.06% | 105 |
|
|
2025
Q2 | $2.89M | Buy |
10,071
+145
| +1% | +$43.3K | 0.04% | 157 |
|
|
2025
Q1 | $3.06M | Buy |
9,926
+3
| +0% | +$1.03K | 0.05% | 127 |
|
|
2024
Q4 | $3.5M | Buy |
9,923
+52
| +0.5% | +$19.1K | 0.08% | 108 |
|
|
2024
Q3 | $3.54M | Sell |
9,871
-29
| -0.3% | -$9.8K | 0.08% | 102 |
|
|
2024
Q2 | $3.15M | Sell |
9,900
-582
| -6% | -$154K | 0.08% | 112 |
|
|
2024
Q1 | $2.41M | Buy |
10,482
+41
| +0.4% | +$9.25K | 0.06% | 173 |
|
|
2023
Q4 | $2.3M | Buy |
10,441
+32
| +0.3% | +$7.38K | 0.06% | 157 |
|
|
2023
Q3 | $2.35M | Sell |
10,409
-2
| -0% | -$461 | 0.06% | 135 |
|
|
2023
Q2 | $2.3M | Buy |
10,411
+299
| +3% | +$66.2K | 0.06% | 140 |
|
|
2023
Q1 | $2.26M | Buy |
10,112
+5,895
| +140% | +$1.45M | 0.06% | 131 |
|
|
2022
Q4 | $1.17M | Sell |
4,217
-2,357
| -36% | -$595K | 0.03% | 202 |
|
|
2022
Q3 | $1.38M | Sell |
6,574
-1,009
| -13% | -$226K | 0.03% | 202 |
|
|
2022
Q2 | $1.79M | Buy |
7,583
+103
| +1% | +$20.9K | 0.04% | 179 |
|
|
2022
Q1 | $1.34M | Buy |
7,480
+14
| +0.2% | +$2.67K | 0.03% | 326 |
|
|
2021
Q4 | $1.61M | Buy |
7,466
+50
| +0.7% | +$9.82K | 0.03% | 309 |
|
|
2021
Q3 | $1.37M | Sell |
7,416
-44
| -0.6% | -$8.67K | 0.03% | 337 |
|
|
2021
Q2 | $1.34M | Buy |
7,460
+30
| +0.4% | +$5.71K | 0.02% | 332 |
|
|
2021
Q1 | $1.24M | Sell |
7,430
-7,850
| -51% | -$1.31M | 0.02% | 347 |
|
|
2020
Q4 | $2.32M | Sell |
15,280
-34
| -0.2% | -$4.46K | 0.03% | 262 |
|
|
2020
Q3 | $1.85M | Hold |
15,314
| – | – | 0.03% | 279 |
|
|
2020
Q2 | $1.85M | Buy |
15,314
+64
| +0.4% | +$7.2K | 0.03% | 278 |
|
|
2020
Q1 | $1.45M | Buy |
15,250
+2,717
| +22% | +$258K | 0.02% | 296 |
|
|
2019
Q4 | $1.1M | Buy |
12,533
+30
| +0.2% | +$2.64K | 0.02% | 456 |
|
|
2019
Q3 | $997K | Buy |
12,503
+8
| +0.1% | +$644 | 0.02% | 485 |
|
|
2019
Q2 | $975K | Buy |
12,495
+4,717
| +61% | +$441K | 0.02% | 480 |
|
|
2019
Q1 | $913K | Sell |
7,778
-461
| -6% | -$53.7K | 0.02% | 594 |
|
|
2018
Q4 | $897K | Buy |
8,239
+28
| +0.3% | +$3.25K | 0.02% | 587 |
|
|
2018
Q3 | $1.05M | Sell |
8,211
-348
| -4% | -$43K | 0.02% | 604 |
|
|
2018
Q2 | $968K | Sell |
8,559
-289
| -3% | -$31.8K | 0.01% | 650 |
|
|
2018
Q1 | $994K | Buy |
8,848
+3,189
| +56% | +$405K | 0.02% | 649 |
|
|
2017
Q4 | $837K | Sell |
5,659
-24
| -0.4% | -$3.05K | 0.01% | 566 |
|
|
2017
Q3 | $666K | Sell |
5,683
-2,073
| -27% | -$265K | 0.01% | 612 |
|
|
2017
Q2 | $1.01M | Buy |
7,756
+8
| +0.1% | +$998 | 0.02% | 564 |
|
|
2017
Q1 | $1.05M | Buy |
7,748
+438
| +6% | +$66.4K | 0.02% | 556 |
|
|
2016
Q4 | $1.05M | Sell |
7,310
-175
| -2% | -$22.3K | 0.02% | 475 |
|
|
2016
Q3 | $884K | Sell |
7,485
-219
| -3% | -$26.3K | 0.02% | 509 |
|
|
2016
Q2 | $816K | Sell |
7,704
-122
| -2% | -$13.6K | 0.02% | 361 |
|
|
2016
Q1 | $872K | Buy |
7,826
+2,370
| +43% | +$300K | 0.02% | 335 |
|
|
2015
Q4 | $854K | Buy |
5,456
+16
| +0.3% | +$2.33K | 0.02% | 402 |
|
|
2015
Q3 | $714K | Hold |
5,440
| – | – | 0.02% | 444 |
|
|
2015
Q2 | $946K | Buy |
5,440
+130
| +2% | +$23.4K | 0.02% | 414 |
|
|
2015
Q1 | $916K | Buy |
+5,310
| New | +$810K | 0.02% | 441 |
|
Other funds holding UTHR
Northwestern Mutual Investment Management Company's UTHR Position: Q2 2026 in Review
Northwestern Mutual Investment Management Company reduced its United Therapeutics (UTHR) stake by 1% in Q2 2026, selling an estimated $55.2K and leaving 9,548 shares worth $5.17M. The position accounts for 0.06% of the portfolio, ranked #96.
Northwestern Mutual Investment Management Company first reported a position in UTHR in Q1 2015 and has held it in 46 quarters since. The position peaked at $5.72M in Q1 2026. 526 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Northwestern Mutual Investment Management Company held 9,548 shares of United Therapeutics worth $5.17M as of Q2 2026.
- Northwestern Mutual Investment Management Company sold 98 United Therapeutics shares in Q2 2026, an estimated $55.2K.
- United Therapeutics made up 0.06% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #96 holding.
- Northwestern Mutual Investment Management Company first reported a position in United Therapeutics in Q1 2015 and has held it in 46 quarters since.
- Northwestern Mutual Investment Management Company's United Therapeutics position peaked at $5.72M in Q1 2026.
- 526 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.